SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-061543
Filing Date
2023-11-09
Accepted
2023-11-09 07:54:48
Documents
66
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrca-20230930.htm   iXBRL 10-Q 2305863
2 EX-10.1 vrca-ex10_1.htm EX-10.1 1040018
3 EX-10.2 vrca-ex10_2.htm EX-10.2 313450
4 EX-10.3 vrca-ex10_3.htm EX-10.3 239400
5 EX-31.1 vrca-ex31_1.htm EX-31.1 15190
6 EX-31.2 vrca-ex31_2.htm EX-31.2 15446
7 EX-32.1 vrca-ex32_1.htm EX-32.1 13626
  Complete submission text file 0000950170-23-061543.txt   10582477

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrca-20230930_lab.xml EX-101.LAB 499536
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrca-20230930_def.xml EX-101.DEF 237561
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrca-20230930_cal.xml EX-101.CAL 57788
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrca-20230930.xsd EX-101.SCH 52868
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrca-20230930_pre.xml EX-101.PRE 378367
60 EXTRACTED XBRL INSTANCE DOCUMENT vrca-20230930_htm.xml XML 1538641
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38529 | Film No.: 231390117
SIC: 2834 Pharmaceutical Preparations